| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |